Ionis Pharmaceuticals IONS Long Term Obligations Current
Discontinued — last reported Q4 '25
Long Term Obligations Current at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:LongTermObligationsCurrent.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's long term obligations current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's long term obligations current?
- Ionis Pharmaceuticals (IONS) reported long term obligations current of -$454.69M in Q4 2025.
- What is the long-term trend for Ionis Pharmaceuticals's long term obligations current?
- Over 2 years (2020 to 2025), Ionis Pharmaceuticals's long term obligations current has grown at a 689.2% compound annual growth rate (CAGR), from $7.3M to -$454.69M.
- What does long term obligations current mean?
- The portion of long-term debts that must be paid within the next year.
- How do you interpret long term obligations current?
- An increase indicates higher near-term cash requirements, which may pressure liquidity if not managed properly.
- How does long term obligations current compare across companies?
- Standard classification for the current portion of long-term debt or other multi-year liabilities.